A new voluntary Medicare model starts in July, and it could save you $11,000 per year. But there are steps you need to take ...
BERLIN, Jan 27 (Reuters) - Roche's experimental obesity drug, which works in a similar way to Eli Lilly's Zepbound, produced ...
Genetic weight loss is reframing obesity medicine by explaining why diets and drugs fail—and how personalized treatment ...
With GLP-1 drugs rising in popularity, how are businesses adapting to a new type of consumer?
New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...
Use BBC.com or the new BBC App to listen to BBC podcasts, Radio 4 and the World Service outside the UK.
Roche’s dual GLP-1/GIP receptor agonist has been tied to 22.5% weight loss at 48 weeks, validating the company’s decision to move the asset into phase 3 studies this quarter.
They’re so easy to incorporate into your week.
'It only makes sense that the weight of passengers impacts costs,' an equity analyst for a financial firm said ...
Jelly Roll showed off his 300-lb weight loss on the red carpet and opened up about being a 'better' dad because of it. Read ...
Analysts say GLP-1 weight-loss drugs could make airfare cheaper by reducing fuel costs as passengers get thinner. Experts ...